To summarize recent progress in our understanding of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders.
INTRODUCTION
A number of Mendelian disorders of immune dysregulation and autoimmunity have been noted to result from defects in T regulatory cells, development and function. The best characterized of these is immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX), resulting from mutations affecting FOXP3. A number of other gene defects that affect T regulatory cell function also give rise to an IPEX-like phenotype, including loss-of-function mutations in CD25, STAT5b and ITCH and gain-of-function mutations in STAT1 (Table 1 ). This review highlights recent progress in the study of these disorders and the identification of underlying genetic and functional causative abnormalities. dysregulation with eczema and food allergy is common, with extremely elevated IgE levels accompanied by intense peripheral eosinophilia and evidence of overt TH2 skewing [1, 7] .
The immunopathogenesis of IPEX relates to the loss of functional CD4 þ CD25 þ T regulatory cells, a subset that is critical to the prevention of 9 & ]. The majority of T regulatory cells are generated in the thymus, express the transcription factor FOXP3, are selected on high-affinity T cell receptor (TCR) interactions with self antigens, and are referred to as natural T regulatory (nT R ) cells [10] [11] [12] . Some FOXP3 þ T regulatory cells can also be induced de novo in vivo from peripheral FOXP3 -CD4 þ cells, resulting in a population of cells (iT R cells) that have regulatory properties but with a TCR repertoire distinct from nT R cells [13,14 & ]. This process can also be recapitulated in vitro by TCR activation of naïve CD4 þ T cells in the presence of transforming growth factor (TGF)-b and interleukin-2. iT R cells are particularly enriched at the mucosal surfaces, especially in the gastrointestinal tract, where they are endowed with a TCR repertoire specific for bacterial antigens [15, 16] . nT R and iT R cells act in synergy to induce peripheral tolerance [13] . Some iT R cell populations can lose expression of FOXP3 and become effector cells, including TH1 and TH17 cells [17] .
Several suppressive mechanisms for T regulatory cells have been demonstrated. These include CTLA4 engagement of B7 molecules on target cells [18, 19] , expression of immunosuppressive cytokines such as interleukin-10, TGF-b, and interleukin-35 [20] [21] [22] , cytotoxicity of target cells through the perforin/ granzyme pathway [23] , induction of indoleamine A number of heritable Mendelian disorders of  autoimmunity and immune dysregulation involve genes  that control various T regulatory cell functions, including  FOXP3, IL2RA, STAT5B, and ITCH. A life-long risk of autoimmune complications attends mutations affecting FOXP3 and related pathways.
KEY POINTS
Gain-of-function mutations in STAT1, normally associated with mucocutaneous candidiasis, may manifest as an IPEX-like phenotype. 2,3-dioxygenase and the catabolism of tryptophan in target cells, as well as consumption of adenosine by expression of CD73, and competition with effector T cells for interleukin-2 because T regulatory cells constitutively express the high-affinity interleukin-2 receptor CD25 [24] [25] [26] [27] . Several of these pathways are targeted by mutations in human subjects, including the interleukin-2 receptor alpha chain (CD25; discussed below), interleukin-10/interleukin-10 receptor, and the perforin/granzyme pathway [28] [29] [30] . Abnormal T regulatory cell function is a key feature of these diseases [31] .
FOXP3 is a transcription factor with a winged helix (Forkhead) DNA-binding domain, a proline rich N-terminal domain, a C 2 H 2 zinc finger motif, and a leucine zipper domain. The leucine zipper domain has been implicated in the formation of homo and heterodimers and higher order assembly of FOXP3 complexes [1, 32] . A number of proteins interact with FOXP3 at its N-terminus, including the transcription factors Hif1a, IRF4, and Eos, the histone acetyltransferases Tip60 and p300, and the histone deacetylase HDAC7, which help to regulate the levels of FOXP3 protein [32,33 & ]. A linker region between the leucine zipper and c-terminal Forkhead domain interacts with the transcription factor AML1/RUNX1, which cooperates with FOXP3 in the suppression of interleukin-2 expression [34] . The Forkhead domain itself interacts with the transcription factor NFAT, relevant to the expression in components of the T regulatory cell transcriptome, including interleukin-2 receptor alpha chain (CD25), GITR and CTLA-4 [35] . FOXP3 may act to induce (e.g., CD25) or suppress (e.g., interleukin-2) gene expression depending on the nature of the interactions with different transcriptional partners at the respective promoter region ,36]. Missense mutations, small in-frame deletions, and deletions and mutations in the promoter and 5' untranslated regions of FOXP3 can be associated with near-normal expression of FOXP3 protein, normal T regulatory cell numbers but with compromised regulatory function, and a milder clinical phenotype. For example, a 1388-bp deletion (g.del-6247-4859) affecting the first untranslated exon and the adjacent intron of FOXP3, a region relevant to the formation of induced T regulatory cells, gave rise to enteropathy, eczema and food allergies, and elevated IgE but no endocrinopathy or cytopenias [37] . Similarly, some N-terminal Foxp3 mutations (for example Q70H and T108 M) gave rise to a milder phenotype without endocrinopathy [38, 39] . Leucine the FOXP3 zipper domain and Forkhead domain mutations are usually associated with more severe phenotypes [6 & ,36] . It is also likely that the genetic background may affect organ involvement, as demonstrated in FOXP3deficient mice, in which organ involvement and disease manifestations vary depending on the strain background [40] .
The immunopathology of FOXP3 deficiency results from unchecked T-cell activation secondary to loss of T regulatory cells that act in a dominant manner to suppress T-cell activation [41, 42] . This is evidenced by the capacity of perinatal adoptive transfer of CD4 þ CD25 þ T regulatory cells to cure FOXP3-deficient mice from disease [13] . Left untreated, disease in FOXP3-deficient mice evolves aggressively and death ensues within a few weeks after birth [43] [44] [45] [46] . Disease progression is associated with lymphoid and myeloid hyperplasia and concomitant intense mixed inflammatory infiltrates involving several organs, including the liver, lung, pancreas, stomach, skin, and gut [43] [44] [45] [46] . The overwhelming majority of CD4 þ and CD8 þ T cells are activated, and TH1, TH2, and TH17 cytokines are abundantly expressed [40] . Inflammation at the mucosal surfaces, including the gut, skin, and lungs, may be driven by unrestrained T cell reactivity to antigens of the commensal flora [ 
CD25 DEFICIENCY
CD25 deficiency in humans manifests similarities to IPEX, but is distinguished by a profound susceptibility to infections. The first description of CD25 deficiency was in a male patient of consanguineous parents who presented with cytomegalovirus (CMV) pneumonitis, oral and esophageal candidiasis, adenoviral gastroenteritis, diarrhea, and failure to thrive [49, 50] . A second case of CD25 deficiency was described in a boy born to unrelated parents who developed severe diarrhea, insulin-dependent diabetes mellitus, and eventual respiratory failure within the first months of life [30] . CMV pneumonitis, enteritis, and Epstein-Barr virus lymphoproliferative disease developed. More recently, a third case of CD25 deficiency was described in a female child of consanguineous parents who developed early-onset eczema and autoimmune enteropathy that was complicated by CMV, bullous pemphigoid, autoimmune thyroiditis, and alopecia universalis [51] .
The presentation of CD25 deficiency has many features of IPEX, but exhibits unique features, including chronic viral, fungal, and bacterial infections [30, 49, 51] . The autoimmune findings are consistent with the pivotal role of CD25 in T regulatory cell biology [52, 53] . Interleukin-2 appears critical for the growth of T regulatory cells, and it has been proposed that one of the key features of interleukin-2 is to expand T regulatory cells [54, 55] . However, two of the reported patients with CD25 deficiency were found to have relatively normal percentages of FOXP3 þ cells in the peripheral blood, suggesting that CD25 signaling is not required for the development of T regulatory cells, which is supported in mouse models [55] . Although CD25 is dispensable for the generation of T regulatory cells, deficiency of CD25 leads to widespread immune dysregulation, arguing that functional responses of T regulatory cells critically depend on interleukin-2. In support of this, in-vivo and in-vitro treatment of T regulatory cells with interleukin-2 appears to enhance their suppressive abilities [55] [56] [57] . In addition, the constitutive expression of CD25 on T regulatory cells allows them to effectively compete for interleukin-2 and act as a cytokine sink that promotes apoptosis in a Bim-dependent manner in effector cells [58, 59] . Finally, interleukin-2 is essential to the generation of induced T regulatory cell populations [60, 61] .
The infectious complications in CD25 deficiency also confirm a role for interleukin-2 in generating effective immunity of T cells (reviewed in [62] ). Interleukin-2 promotes the proliferation and development of TH1 and TH2 cells [63] [64] [65] [66] . In contrast, interleukin-2 appears to inhibit TH17 development, but, once generated, TH17 cells may utilize interleukin-2 to expand [67, 68] . Interleukin-2 also inhibits T follicular helper T cells, development [69, 70] . Interleukin-2 is important in generating cytotoxic CD8 effector cells as well as memory CD8 cells through the induction of interferon-g, perforin and granzyme expression [71, 72] . Interleukin-2 can activate natural killer (NK) cells to become lymphokine-activated killer cells, and interleukin-2 has been reported to promote B-cell response [73, 74] . The pleiotropic effects of interleukin-2 on the effector function of the adaptive immune response helps to explain why individuals lacking CD25 exhibit increased susceptibility to infections, including fungus, bacteria, and viruses.
STAT5b DEFICIENCY
STAT5 consists of two closely related proteins, STAT5a and STAT5b, that are the product of two distinct genes and are 90% homologous [75, 76] . Complete deficiency in STAT5 proteins in mice results in perinatal lethality because these proteins are involved in the signal transduction of a variety of growth factors, including growth hormone, prolactin, erythropoietin, interleukin-3, interleukin-5, and granulocyte-macrophage colony-stimulating factor [77, 78] . Defects in STAT5a have not been described. Defects in STAT5b have been described to result from deletion, missense, and splice junction mutations, and are inherited in an autosomal recessive manner.
The original description of STAT5b deficiency was of an Argentinean girl with growth failure, delayed puberty, prominent forehead, saddle nose, and high pitched voice, all features of growth hormone deficiency [79] . Since then, several other patients have been described [80] [81] [82] [83] [84] [85] . Common clinical presentations include failure to thrive and growth failure, recurrent infectious pneumonias due to bacterial and viral infections, lymphoid interstitial pneumonitis, severe varicella and recurrent bouts of herpes zoster, and chronic diarrhea and eczema. Laboratory studies usually demonstrate hypergammaglobulinemia, with normal T, B, and NK cell numbers, although the T cells may show severe memory skewing. FOXP3 þ T regulatory cells may be normal or slightly decreased. Mitogenic responses may be low; low insulin-like growth factor-1, low insulin-like growth factor-binding protein-3, and high prolactin are usually present, reflecting the defective growth hormone receptor signaling.
Many of the features of STAT5b deficiency are similar to findings in CD25 deficiency, including eczema, chronic diarrhea, thyroiditis, and increased susceptibility to infections, likely because of the fact that interleukin-2 receptor signaling requires STAT5. Pulmonary disease appears more prominent in STAT5b deficiency, although it is unclear whether this is driven by infectious processes, or is the result of defective immune regulation. Similarly to CD25 deficiency, signs of immune activation may be apparent, including hypergammaglobulinemia and increased percentages of CD45RO positive T cells. The severity of disease in STAT5b deficiency appears more variable and less severe compared with CD25 deficiency, likely because of the fact that STAT5a may substitute for some of the functions of STAT5b. The increased susceptibility to infections and autoimmune manifestations of STAT5b deficiency is likely because of defects in responsiveness to interleukin-2, as outlined in CD25 deficiency above.
IMMUNE DYSREGULATION, POLYENDOCRINOPATHY, ENTEROPATHY, X-LINKED-LIKE DISEASE DUE TO STAT1 MUTATIONS
Autosomal dominant heterozygous gain-of-function mutations in STAT1 have been found in patients with mucocutaneous candidiasis. Some of the affected patients suffered from autoimmunity, mainly autoimmune thyroiditis, but otherwise lacked other characteristics of the autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (AEPECD) phenotype, including characteristic endorgan targets of autoimmunity and ectodermal dysplasia [86] [87] [88] . By screening patients with IPEX-like phenotype with or without mucocutaneous candidiasis, Uzel et al. [89 && ] identified five patients with heterozygous gain-of-function STAT1 mutations. The mutations involved the coiled-coil (R210I, V266I) and DNA-binding domains [L358W, T385 M (two patients)] of STAT1. These mutations resulted in increased STAT1 phosphorylation at the regulatory tyrosine 701, consistent with the gain-of-function phenotype of the mutations.
Gain-of-function STAT1 mutations inhibit TH17 cell differentiation, a phenotype associated with heightened susceptibility to mucocutaneous candidiasis. However, the mechanism of IPEX-like disease in some of the patients remains unclear. The number of T regulatory cells and their in-vitro suppressor function appeared normal [89 && ]. It is possible that the gain-of-function STAT1 mutant destabilizes the T regulatory cells by reprogramming them into TH1-like cells, but that remains to be determined. Interleukin-10 production by peripheral blood lymphocytes was profoundly decreased, suggesting a role for functional interleukin-10 deficiency in certain aspects of disease manifestation (such as enteritis).
All five patients presented with eczema and enteropathy [89 && ]. Three of the patients developed type 1 diabetes, three developed hypothyroidism and/or thyroid autoantibodies, and one patient developed growth hormone insufficiency. All patients suffered from recurrent infections, with various combinations of sinopulmonary infections and pneumonias (with or without bronchiectasis), herpes virus infections, and blood-borne infections. The patients also suffered from a variety of cardiovascular problems, including hypertension, vascular aneurysms, and calcifications. Four of the five patients exhibited mucocutaneous candidiasis, suggesting that the disease may occasionally present in the absence (or cryptic presence) of candidiasis [89 && ]. Disseminated aspergillosis and candidemia have been noted in two patients under conditions of immunosuppression and catheter related, respectively.
ITCH
Human ITCH deficiency was discovered in an extended Amish family with findings of multisystem autoimmunity, dysmorphic features, and developmental abnormalities. due to a single adenine nucleotide insertion in codon 132 of the ITCH gene, resulting in a frame-shift and premature stop codon [90] . Ten affected individuals were found to carry this mutation. Autosomal recessive inheritance was apparent in this extended family, and prominent consanguinity was noted. A naturally occurring mutation in Itch, the mouse homologue of human ITCH, recapitulates many features of the human disease, including a severe autoimmune disorder characterized by dermatitis, chronic pulmonary inflammation, alveolar proteinosis, and lymphoid hyperplasia [91] . Studies with Itchdeficient mice have elucidated some of the potential mechanisms of immune dysregulation in these mice. ITCH is an ubiquitin ligase with diverse function, in T cells [91] . T cells from Itch -/mice show an activated phenotype with enhanced proliferation and expression of the TH2 cell cytokines interleukin-4 and interleukin-5 [92] . IgG1 and IgE levels were elevated, consistently with a prominent TH2 response in these mice. These studies identified JunB, a transcription factor that is involved in TH2 differentiation, as a target of ITCH [93, 94] . Other studies have shown that ITCH is upregulated in anergic T cells, and ITCH associates with phospholipase C, gamma 1 (PLC-g1) and protein kinase C (PKC)-u, two key signaling molecules induced by Ca 2þ / calcineurin signaling [95] . Following ITCH-mediated ubiquitination, PLC-g1 and PKC-u are targeted to the lysosome for degradation, leading to reduced levels of PLC-g1 and PKC-u and defective T cell activation.
ITCH has also been implicated in T regulatory cell function and generation, mainly through its affects on TGF-b signaling and FOXP3 expression in CD4 T cells [96] . The loss of ITCH compromises TGF-b-induced FOXP3 expression and TGF-b-mediated inhibition of T-cell proliferation through the ubiquitination of the transcription factor TIEG1. Upon ubiquitination by ITCH, TIEG1 translocates to the nucleus, and binds GC-rich sequences in the FOXP3 promoter [96] .
SUMMARY AND FUTURE DIRECTIONS
Despite the progress in identifying several IPEX-like diseases and establishing their genetic causations, the underlying defects in a large proportion of patients who present with IPEX-like disorders remain obscure. The advent of global sequencing approaches such as whole-genome and wholeexome sequencing promises to identify novel gene defects and exciting new pathways operative in tolerance and autoimmunity.
